FDA APPROVAL
LEXICON ANNOUNCES FDA APPROVAL OF INPEFA (SOTAGLIFLOZIN) FOR TREATMENT OF HEART FAILURE
SG Tylor
Lexicon Pharmaceuticals on May 26, 2023 announced that the US Food and Drug Administration (FDA) has approved INPEFAā¢ (sotagliflozin), a once-daily ...
ALLERGANāS LATEST SKIN-SMOOTHING PRODUCT HAS RECEIVED FDA APPROVAL, FEATURING A UNIQUE DELIVERY MECHANISM
SG Tylor
Allergan has recently obtained FDA approval for its groundbreaking skincare product, Skinvive, which is part of the Juvederm dermal filler ...
EPCORITAMAB RECEIVES FDA APPROVAL FOR RELAPSED/REFRACTORY DLBCL
SG Tylor
The FDA has granted approval to epcoritamab-bysp (Epkinly), the first T-cellāengaging bispecific antibody, for the treatment of relapsed/refractory diffuse large ...
